Mr. Speaker, I was so absorbed by the speech made by my colleague from Hochelaga—Maisonneuve that I had forgotten to return to my seat.
I want to congratulate my colleague for his perseverance in this matter. He has shown us again today his great sensitivity with regard to the whole issue of tainted blood and the Krever report. We all know that he has been a great champion of this cause.
I would like to ask my colleague to explain to us, if we were to compensate victims infected before 1986 and after 1990, what impact that would have, on a daily basis, on the quality of life of those victims of tainted blood. How would this decision improve their quality of life? I remember seeing them saddened by the minister's response, when he turned them down. To them, it would have been a step toward a better quality of life.
I would like my colleague to comment on that so we can better understand this issue which, even after several years, is still being debated today.